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Introduction
We know that many of the most common 
causes of corneal blindness: vitamin A 
deficiency, trachoma, and ophthalmia 
neonatorum, can be prevented by simple 
primary health care measures. Some condi-
tions are more difficult to prevent, but can 
be effectively treated, such as suppurative 
keratitis (page 39) or herpes simplex 
keratitis. However, some patients will still 
develop blinding corneal disease. What can 
be done for them? 
At present, the best hope for curing 
corneal blindness is a corneal transplant, 
also known as a corneal graft. 
In contrast with most other transplants, 
corneal grafting is relatively straightforward. 
Although additional surgical training is 
needed, the operation itself requires little 
equipment beyond a standard cataract set 
and a good operating microscope. Because 
there are no blood vessels in the cornea, 
the likelihood of rejection is less than for 
other transplants. 
In this article, we want to provide guidance 
to eye care workers who want to know who 
should be referred for a graft and what 
complications they may need to manage 
after patients have had their operation. 
What is corneal grafting?
In this operation, the central 7–8 mm of the 
patient’s own diseased cornea is removed. 
A similar-sized disc of donor cornea is then 
inserted and sutured into position. In most 
cases, the full thickness of the cornea, 
including epithelium, stroma, and endothelium, 
is transplanted; this is known as a penetrating 
graft. However, it is also possible to trans-
plant just the outer, anterior layers (stroma 
and epithelium) or the inner, posterior layers 
(endothelium and Descemet’s membrane). 
Indications and prognoses
Any corneal disorder that causes visual 
impairment may be an indication for a 
corneal graft. However, the prognosis for 
corneal grafting varies greatly. 
The risk of rejection is higher if the 
cornea is vascularised (contains blood 
vessels), or is inflamed or perforated (as is 
liable to occur in severe suppurative 
keratitis, for example). The same holds true 
for any eye that has generalised disease of 
the ocular surface. 
Table 1 lists some of the different 
diagnoses that may be treated by a corneal 
graft, along with their prognoses. Conditions 
with a “very poor” prognosis should not be 
treated by corneal grafting as this is a waste 
of valuable transplant tissue.
The visual prognosis for a corneal graft is 
also affected by the state of the rest of the 
eye, not just the cornea and ocular surface. 
Uncontrolled intraocular pressure (IOP) is a 
contraindication to grafting, as IOP control is 
likely to be worsened by a corneal graft. 
Patients with known posterior segment 
disease affecting the retina or optic nerve 
are also unlikely to benefit.  
A corneal graft requires much more 
postoperative care than a cataract 
extraction. This entails repeated clinic visits 
and using expensive eye drops frequently; 
therefore, the patient must value their new 
cornea and be motivated to take care of it. 
Patients are most likely to value their new 
cornea if the grafted eye is their better eye. 
In general, this means that patients with 
unilateral disease and perfect vision in the 
other eye are poor candidates. There are 
exceptions: for example, if the eye is painful 
as well as visually impaired. 
Corneal grafting in children has a very 
poor prognosis and requires more intense 
postoperative care; it should therefore be 
considered carefully.
Outcomes 
Studies from South India1 showed that
69 per cent of grafted corneas were clear 
at two years after surgery. In East Africa,2
87 per cent of grafts for keratoconus 
survived for at least two years, compared to 
65 per cent performed for other diagnoses. 
Unfortunately, a clear graft does not 
guarantee good vision. Patients may have 
coexisting problems, such as glaucoma, 
cataract, or amblyopia. Because corneal 
grafting alters the shape of the cornea, it 
often causes significant astigmatism, which 
can be difficult to correct with spectacles. 
Visual outcomes in East Africa2 were 
much better for patients with keratoconus 
than for those with other diagnoses. 
In patients grafted for keratoconus, 
33 per cent were <6/60 in both eyes 
preoperatively, compared to 5 per cent 
post-operatively; 78 per cent could see 
6/18 or better following surgery. This data 
showed that corneal grafting is an effective 
cure for blindness caused by keratoconus.
This also demonstrates the importance 
of monitoring and reporting the outcomes of 
corneal graft operations.
 
Complications
The main causes of graft failure in both 
South India1 and East Africa2 were graft 
rejection and infectious keratitis. Both of 
these complications are treatable and often 
preventable. In many cases, graft failure 
could have been prevented by early and 
effective management at a local eye clinic. 
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Diagnosis Prognosis
Keratoconus Excellent
Corneal dystrophies, such as lattice, granular, Fuch’s Excellent
Corneal scar – healed ulcer Moderate
Bullous keratopathy – aphakic or pseudophakic Moderate
Herpes simplex keratitis Moderate
Corneal scar: active ulcer/keratitis, threatened perforation
(grafting may be done to salvage the eye, rather than vision)
Poor 
Corneal scar: trachoma Very poor
Ocular surface disorder: chemical burn, Stevens-Johnson syndrome Very poor
Mooren’s ulcer Very poor
Re-graft Very poor
Table 1. Indicaions for corneal graft and their prognoses
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Figure 1. Keratoconus. Note the central 
scarring, with thinning and ectasia
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Graft rejection is caused by an immune 
reaction directed against the foreign 
endothelial cells of the transplanted cornea. 
Approximately 20–30 per cent of 
penetrating grafts will have a rejection 
episode at some time. The most common 
symptoms of graft rejection are blurred 
vision, light sensitivity, redness, and pain; 
patients should be advised to attend an eye 
clinic immediately if they develop any of 
these symptoms. Rejection is recognised by 
the appearance of corneal oedema in a 
previously clear graft. The oedema usually 
spreads upwards across the graft from the 
inferior edge of the transplanted cornea. 
The eye is often inflamed and a line of 
keratic precipitates may be seen at the edge 
of the oedematous cornea. 
Preventing rejection begins with 
selection for surgery. Some diagnoses, such 
as keratoconus and other corneal dystro-
phies, have a very low risk of rejection. 
Following surgery, rejection is prevented by 
topical steroid drops. These are used at 
different frequencies for varying lengths of 
time, depending on the underlying diagnosis 
and the perceived risk of rejection. Whatever 
steroid regime is used, the drops should 
never be suddenly stopped, but should 
always be tailed off gradually. The usual 
duration of steroid therapy following a full 
thickness graft is six months in phakic 
patients and twelve months in pseudo-
phakic or aphakic patients. 
With prompt diagnosis and immediate 
treatment, graft rejection can often be 
reversed. The recommended management 
of graft rejection is intensive steroid 
treatment, initially in the form of hourly 
topical steroid drops. The use of systemic 
steroids, such as 500 mg methylpred-
nisolone, has been shown to make little 
difference to the outcome and the authors 
therefore do not recommend it. 
Infection
The second common cause of graft failure is 
suppurative keratitis. This presents in the 
same way as any other microbial keratitis 
(page 39). Patients with corneal grafts are 
at increased risk of corneal infection 
because they have reduced corneal 
sensation and are often on long-term 
topical steroids. The management of infec-
tious keratitis is the same in these patients 
as it is for anyone else. A scraping should be 
taken for gram stain and culture if available 
(see page 42). Intensive antibiotic 
treatment, either monotherapy with a 
topical fluoroquinolone (such as ofloxacin) 
or combination treatment with a cepha-
losporin (such as cefuroxime) and an 
aminoglycoside (such as gentamicin) is 
started immediately after the scraping has 
been taken, and is continued for at least 
48 hours. In some settings, anti-fungal 
treatment may be required. 
Loose suture
The most common predisposing factor for 
infectious keratitis following a corneal graft 
is a loose suture. With time, as the graft 
wound heals, the very fine sutures either 
break or become loose. In both cases, they 
will erode through the corneal epithelium. 
This destroys the barrier effect of the 
epithelium and allows microorganisms to 
get into the cornea where they cause 
infection. A loose suture also promotes the 
growth of blood vessels into the cornea, 
which can lead to rejection.
All loose or broken sutures which 
protrude through the epithelium should be 
removed immediately. They can be detected 
by staining the cornea with fluorescein. Eye 
workers are sometimes reluctant to remove 
a corneal suture for fear that it may be the 
only thing holding the cornea together! This 
is an understandable reaction; however, if 
the stitch is loose or broken, then it cannot 
be providing any support to the wound. It is 
not serving any useful purpose and greatly 
increases the risk of complications, and it 
should be removed urgently. 
To remove the suture, give local anaes-
thetic drops three times and wait three to 
five minutes. Cut the suture with the sharp 
edge of a 26G needle. Using a pair of very 
fine forceps, grasp the end of the stitch and 
pull it gently out of the eye. Always give 
antibiotic drops for five days afterwards to 
prevent infection. 
Summary
• Most corneal blindness can be prevented, 
but for those patients who have bilateral 
visual impairment caused by corneal 
disease, a corneal graft is the only hope of 
restoring sight. 
• The best candidates for a corneal graft are 
patients with keratoconus or other corneal 
dystrophy, in whom about 90 per cent of 
grafts will remain clear for at least two years. 
• Good postoperative care is essential. 
Patients must remain on topical steroids 
for a long time, and these should never be 
stopped suddenly. 
• Graft rejection is often reversible if it is treated 
immediately with intensive topical steroids. 
• All loose sutures should be removed 
immediately to reduce the risk of microbial 
keratitis. 
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Figure 2. Graft rejection. Note oedema in the lower two-thirds of the graft (Figure 2a) along with multiple keratic precipitates (Figure 2b)
Figure 3. A broken stitch has caused blood 
vessels to grow into the corneal graft, 
increasing the risk of rejection. It is surrounded 
by infiltrate, which may indicate infection
Figure 2a Figure 2b
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